Member Info for WeTookPelham

https://metro.co.uk/2021/04/16/first-cases-of-double-mutant-covid-from-india-found-in-uk-14418472/

https://www.nottinghampost.com/news/local-news/university-nottingham-recruiting-trial-2-5294546

"UoN Professor David Turner and Honorary Consultant in Clinical Microbiology at Nottingham University Hospitals NHS Trust is Principle Investigator on the study.

He said: “This is an important next step in studying the effects of alternating different vaccines in patients.
"With new vaccines continuing to be approved all the time, if we show the immune response to mixed vaccine schedules is as effective as with the two doses of the same vaccine, then this could lead to more people being able to have their complete vaccination course more quickly. It will also reduce the risk of supply issues with each vaccination.”"

So why Nottingham uni? Either way you'd think Scancell will be very close attention this, and no doubt there will be mutual contacts between this trial and the Covidty project? IMO.

As a LTH, if someone had told me I'd be"adding" at these prices this time last year I would have probably laughed in their faces, but shows how the company has changed and developed in the last 12 months, and let's not forget we've not even had the long awaited deal(s) or trials news yet.

Yes this Algo fella is clearly minted.

Hi Hasiba, how can you tell? What's the tell tale signs?

Or the Americans have had their coffee and bagels.

?
23.15p paid too.

Very significant IMO, J&J is the main vaccine for America right? Also J&J is the same type of vaccine as Astras right?

Is it up 3.07% or 0.44%?

Interestingly the market reaction to Open Orphans news is mixed to say the least.

A fair point Cleanerworld, immumobody, moditope, Avidimab could be very easily be standalone spin outs IMO.
Maybe Scancell/Redmile and more importantly a big pharma want the whole shebang?

Yeah just heard that myself, not sure who was talking about Scancell (wasn't Zak Mir), but a good summary of the scenario, under 30's not getting the Astra vaccine and under 30's spreading the virus, this leading to giving covid mututations the (ideal?) scenario to thive. Belives we could back to a bad situation come autumn. I personally would have agree with these points.
He also mentioned he bought in to SCLP.

More about this:

https://www.cityam.com/south-african-covid-variant-able-to-break-through-pfizer-vaccine-israeli-study-warns/

https://www.forbes.com/sites/williamhaseltine/2021/03/17/astrazeneca-vaccine-fails-to-protect-against-the-south-african-variant/ (with the news of blood clots and findings such as this it's not great news for Astra nor it's uptake...IMO)

https://www.bbc.co.uk/news/uk-england-manchester-56582721 (Not sure if I missed this)

But yes tweaks to existing vaccines needed asap...AND getting covidity testing started ASAP...IMO.

Dr Kariko... interestingly Scancell Twitter just started following her the other day.

Very interesting IMO.
Biotech start-up behind AstraZeneca vaccine files for US listing
Vaccitech IPO likely to be seen as a loss for London as UK seeks to become hub for life sciences investment.

https://www.ft.com/content/ff260c57-66f9-474b-9643-7640dc918009

Lol...don't encourage them!

Sorry, refer to todays RNS for Deep matter.

https://www.lse.co.uk/ShareChat.asp?ShareTicker=DMTR&share=Deepmatter

Interesting? Very useful sounding product regardless.

https://www.bloomberg.com/news/articles/2021-04-05/covid-mutants-multiply-as-scientists-race-to-decode-variations?srnd=premium-europe

https://www.thetimes.co.uk/article/clear-link-between-blood-clots-and-astrazeneca-vaccine-q8nvl82p5